October 10, 2022 03:08 PM EDT DealsM&A options? Analysts break...

October 10, 2022 03:08 PM EDT Deals

M&A options? Analysts break down what's hot right now.

Here's an article about M+A activity today.

The last paragraph might add some additional knowledge to the thought process.

With the number of biopharma acquisitions in 2022 so far falling below recent years, the investment bank SVB Securities on Sunday published a new report on M&A and where there may be some action in the near term.......

......the report says that in the wider space,none of these companies is mature enough, in our view, to generate near-term unpartnered revenue and EPS accretion to an acquirer.

Attractive M&A options? Analysts break down what's hot right now

Attractive M&A options? Analysts break down what's hot right now With the number of biopharma acquisitions in 2022 so far falling below recent years, the investment bank SVB Sec...